CIK: 0001595851 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 15, 2018
Total Value: $494M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | 8,333 | $83.33M | 16.9% | $10000.00 * | $119.92 | -24.8% | Put | 45337C102 |
| XBI | SPDR SERIES TRUST | 8,773 | $35.09M | 7.1% | $4000.00 | — | — | Put | 78464A870 |
| — | IMMUNOMEDICS INC | 1,850,000 | $27.03M | 5.5% | $14.61 | $8.35 | — | COM | 452907108 |
| — | ENDOCYTE INC | 2,200,000 | $20M | 4.0% | $9.09 | $9.09 | — | COM | 29269A102 |
| SRPT | SAREPTA THERAPEUTICS INC | 235,000 | $17.41M | 3.5% | $74.09 * | $66.68 | 0.0% | COM | 803607100 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,000,000 | $16.9M | 3.4% | $16.90 * | $15.14 | 0.0% | COM | 462260100 |
| — | AVEXIS INC | 135,000 | $16.68M | 3.4% | $123.58 | $76.96 | — | COM | 05366U100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 850,000 | $15.94M | 3.2% | $18.75 * | $16.31 | 0.0% | COM | 77313F106 |
| — | MYLAN N V | 350,000 | $14.41M | 2.9% | $41.17 | $41.99 | — | SHS EURO | N59465109 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 550,000 | $14.17M | 2.9% | $25.76 | $26.17 | — | COM | G11196105 |
| ARGX | ARGENX SE | 150,000 | $12.07M | 2.4% | $80.44 | $21.52 | — | SPONSORED ADR | 04016X101 |
| — | CATALYST BIOSCIENCES INC | 450,000 | $11.61M | 2.3% | $25.80 | $25.80 | — | COM NEW | 14888D208 |
| FOLD | AMICUS THERAPEUTICS INC | 750,000 | $11.28M | 2.3% | $15.04 | $15.22 | 0.0% | COM | 03152W109 |
| — | BLUEPRINT MEDICINES CORP | 120,000 | $11M | 2.2% | $91.70 | $75.41 | — | COM | 09627Y109 |
| ASND | ASCENDIS PHARMA A S | 140,000 | $9.156M | 1.9% | $65.40 | $37.01 | — | SPONSORED ADR | 04351P101 |
| — | DICERNA PHARMACEUTICALS INC | 950,000 | $9.082M | 1.8% | $9.56 | $9.28 | — | COM | 253031108 |
| — | MOMENTA PHARMACEUTICALS INC | 500,000 | $9.075M | 1.8% | $18.15 | $18.15 | — | COM | 60877T100 |
| ACAD | ACADIA PHARMACEUTICALS INC | 400,000 | $8.988M | 1.8% | $22.47 * | $27.69 | 0.0% | COM | 004225108 |
| — | MIRATI THERAPEUTICS INC | 262,500 | $8.059M | 1.6% | $30.70 | $18.25 | — | COM | 60468T105 |
| — | CONCERT PHARMACEUTICALS INC | 350,000 | $8.015M | 1.6% | $22.90 | $22.90 | — | COM | 206022105 |
| — | ADAMAS PHARMACEUTICALS INC | 325,000 | $7.766M | 1.6% | $23.90 | $23.90 | — | COM | 00548A106 |
| — | ALLERGAN PLC | 45,000 | $7.573M | 1.5% | $168.29 | $163.58 | — | SHS | G0177J108 |
| — | ASSEMBLY BIOSCIENCES INC | 150,000 | $7.371M | 1.5% | $49.14 | $49.14 | — | COM | 045396108 |
| — | RETROPHIN INC | 314,367 | $7.029M | 1.4% | $22.36 | $22.36 | — | COM | 761299106 |
| — | KADMON HLDGS INC | 1,600,000 | $6.8M | 1.4% | $4.25 | $3.86 | — | COM | 48283N106 |
| — | AVADEL PHARMACEUTICALS PLC | 850,000 | $6.197M | 1.3% | $7.29 | $7.29 | — | SPONSORED ADR | 05337M104 |
| VRAYQ | VIEWRAY INC | 900,000 | $5.787M | 1.2% | $6.43 * | $6.99 | +19.3% | COM | 92672L107 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 800,000 | $5.768M | 1.2% | $7.21 * | $6.16 | 0.0% | COM | 04280A100 |
| — | AQUINOX PHARMACEUTICALS INC | 400,000 | $5.632M | 1.1% | $14.08 | $13.70 | — | COM | 03842B101 |
| — | G1 THERAPEUTICS INC | 150,000 | $5.558M | 1.1% | $37.05 | $37.05 | — | COM | 3621LQ109 |
| PTCT | PTC THERAPEUTICS INC | 200,000 | $5.412M | 1.1% | $27.06 * | $25.34 | 0.0% | COM | 69366J200 |
| — | OBSEVA SA | 400,000 | $5.398M | 1.1% | $13.49 | $9.76 | — | COM | H5861P103 |
| — | NEOS THERAPEUTICS INC | 600,000 | $4.98M | 1.0% | $8.30 | $7.80 | — | COM | 64052L106 |
| — | ADURO BIOTECH INC | 500,000 | $4.65M | 0.9% | $9.30 | $9.30 | — | COM | 00739L101 |
| — | CURRENCYSHARES SWISS FRANC T | 45,800 | $4.507M | 0.9% | $98.41 | $98.41 | — | SWISS FRANC SH | 23129V109 |
| — | MERSANA THERAPEUTICS INC | 278,244 | $4.388M | 0.9% | $15.77 | $15.77 | — | COM | 59045L106 |
| TGTX | TG THERAPEUTICS INC | 300,000 | $4.26M | 0.9% | $14.20 * | $12.78 | 0.0% | COM | 88322Q108 |
| — | GLYCOMIMETICS INC | 250,000 | $4.058M | 0.8% | $16.23 | $16.23 | — | COM | 38000Q102 |
| — | LANNET INC | 250,000 | $4.013M | 0.8% | $16.05 | $16.05 | — | COM | 516012101 |
| — | CLOVIS ONCOLOGY INC | 75,000 | $3.96M | 0.8% | $52.80 | $68.00 | — | COM | 189464100 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 1,750,000 | $3.675M | 0.7% | $2.10 | $2.14 | 0.0% | COM | 45665G303 |
| — | TESARO INC | 61,900 | $3.537M | 0.7% | $57.14 | $57.14 | — | COM | 881569107 |
| — | SOLID BIOSCIENCES INC | 385,000 | $2.888M | 0.6% | $7.50 | $7.50 | — | COM | 83422E105 |
| — | JOUNCE THERAPEUTICS INC | 125,092 | $2.796M | 0.6% | $22.35 | $22.35 | — | COM | 481116101 |
| — | DBV TECHNOLOGIES S A | 100,000 | $2.307M | 0.5% | $23.07 | $35.76 | — | SPONSORED ADR | 23306J101 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 75,100 | $1.935M | 0.4% | $25.77 | $26.17 | — | Call | G11196105 |
| — | SAGE THERAPEUTICS INC | 11,100 | $1.788M | 0.4% | $161.08 | $164.69 | — | COM | 78667J108 |
| CPRX | CATALYST PHARMACEUTICALS INC | 550,000 | $1.315M | 0.3% | $2.39 * | $3.30 | +0.6% | COM | 14888U101 |
| — | KARYOPHARM THERAPEUTICS INC | 76,786 | $1.03M | 0.2% | $13.41 | $13.41 | — | COM | 48576U106 |
| — | NABRIVA THERAPEUTICS PLC | 200,000 | $1.006M | 0.2% | $5.03 | $7.31 | — | SHS | G63637105 |
| ANAB | ANAPTYSBIO INC | 9,000 | $937K | 0.2% | $104.11 * | $112.70 | 0.0% | COM | 032724106 |
| — | MOTUS GI HLDGS INC | 100,000 | $448K | 0.1% | $4.48 | $4.48 | — | COM | 62014P108 |
| — | IMMUNOGEN INC | 7,500 | $225K | 0.0% | $30.00 | $30.00 | — | COM | 45253H101 |